These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 33802174)
1. Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix. Takayanagi D; Hirose S; Kuno I; Asami Y; Murakami N; Matsuda M; Shimada Y; Sunami K; Komatsu M; Hamamoto R; Kato MK; Matsumoto K; Kohno T; Kato T; Shiraishi K; Yoshida H Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802174 [TBL] [Abstract][Full Text] [Related]
2. Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix. Liu R; He X; Li Z Front Pharmacol; 2022; 13():1029598. PubMed ID: 36467090 [TBL] [Abstract][Full Text] [Related]
3. Comparative genomics of high grade neuroendocrine carcinoma of the cervix. Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169 [TBL] [Abstract][Full Text] [Related]
4. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix. Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425 [TBL] [Abstract][Full Text] [Related]
5. PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervix. Morgan S; Slodkowska E; Parra-Herran C; Mirkovic J Histopathology; 2019 Jun; 74(7):997-1004. PubMed ID: 30667073 [TBL] [Abstract][Full Text] [Related]
6. Imaging and staging of neuroendocrine cervical cancer. Elsherif S; Odisio EGLC; Faria S; Javadi S; Yedururi S; Frumovitz M; Ramalingam P; Bhosale P Abdom Radiol (NY); 2018 Dec; 43(12):3468-3478. PubMed ID: 29974177 [TBL] [Abstract][Full Text] [Related]
7. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1. Liu J; Liu Y Pathol Res Pract; 2020 Feb; 216(2):152797. PubMed ID: 31926773 [TBL] [Abstract][Full Text] [Related]
8. Natural history and outcome of neuroendocrine carcinoma of the cervix. Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865 [TBL] [Abstract][Full Text] [Related]
9. Comparative molecular profiling of HPV-induced squamous cell carcinomas. Koncar RF; Feldman R; Bahassi EM; Hashemi Sadraei N Cancer Med; 2017 Jul; 6(7):1673-1685. PubMed ID: 28556593 [TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing identifies common mutational landscape of cervix and endometrium small cell neuroendocrine carcinoma. Wang W; Zhang F; Li Y; Chen B; Gu Y; Shan Y; Li Y; Chen W; Jin Y; Pan L Front Oncol; 2023; 13():1182029. PubMed ID: 37920164 [TBL] [Abstract][Full Text] [Related]
11. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva. Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519 [TBL] [Abstract][Full Text] [Related]
13. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status. Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262 [TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus Infection, p16 Van Ta T; Nguyen QN; Truong VL; Tran TT; Nguyen HP; Vuong LD Malays J Med Sci; 2019 Sep; 26(5):151-157. PubMed ID: 31728128 [TBL] [Abstract][Full Text] [Related]
15. High-Grade Neuroendocrine Carcinoma of the Head and Neck: Human Papillomavirus Status and PD-L1 Expression. Bahr K; Zimmer S; Springer E; Fottner C; Becker S; Ernst BP; Matthias C; Künzel J ORL J Otorhinolaryngol Relat Spec; 2019; 81(5-6):309-316. PubMed ID: 31550725 [TBL] [Abstract][Full Text] [Related]
16. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva. Howitt BE; Sun HH; Roemer MG; Kelley A; Chapuy B; Aviki E; Pak C; Connelly C; Gjini E; Shi Y; Lee L; Viswanathan A; Horowitz N; Neuberg D; Crum CP; Lindeman NL; Kuo F; Ligon AH; Freeman GJ; Hodi FS; Shipp MA; Rodig SJ JAMA Oncol; 2016 Apr; 2(4):518-22. PubMed ID: 26913631 [TBL] [Abstract][Full Text] [Related]
17. Role of HPV status and PD-L1 expression in prognosis of laryngeal squamous cell carcinoma. Yang SM; Wu M; Han FY; Sun YM; Yang JQ; Liu HX Int J Clin Exp Pathol; 2021; 14(1):107-115. PubMed ID: 33532028 [TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway. Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844 [TBL] [Abstract][Full Text] [Related]
19. PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line. Lai ZY; Yeo HY; Chen YT; Chang KM; Chen TC; Chuang YJ; Chang SJ Oncotarget; 2017 Jul; 8(28):45323-45334. PubMed ID: 28484083 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Iwasawa A; Nieminen P; Lehtinen M; Paavonen J Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]